Fengmei Xu

机构：Hefei Design and Research Institute of Coal Industry (China)

发表论文 26 篇 · 总被引 588 次 · h-index 9

代表论文

• Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (2024 · New England Journal of Medicine · 被引 213)
• Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study (2020 · BMJ Open Diabetes Research & Care · 被引 111)
• Inactivation of the antidiabetic drug acarbose by human intestinal microbial-mediated degradation (2023 · Nature Metabolism · 被引 55)
• Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes—A multicenter cross-sectional observational study across China (2019 · PLoS ONE · 被引 42)
• Follow‐up frequency and clinical outcomes in patients with type 2 diabetes: A prospective analysis based on multicenter real‐world data (2022 · Journal of Diabetes · 被引 40)
• hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells (2016 · Scientific Reports · 被引 29)